Bal Krishna Mishra

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Gut microbiome and immunotherapy in advanced non–small cell lung cancer: a prospective cohort study
  BMC Cancer 2026 DOI: 10.1186/s12885-026-16683-y
  +Save
• KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms
  Medical Oncology 2026 DOI: 10.1007/s12032-026-03318-2
  +Save
• Impact of Trastuzumab on Survival Outcomes in Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Cancers: A Real-World Analysis From a High-Incidence Region (REAL TAB)
  JCO Oncology Advances 2026 DOI: 10.1200/OA-25-00220
  +Save
• Navigating the Genetic Frontier: Establishing Genetic Clinics for Comprehensive Hereditary Cancer Management in Resource-Limited Settings
  Indian Journal of Medical and Paediatric Oncology 2026 DOI: 10.1055/s-0045-1811249
  +Save
• Sustained Complete Response to Brigatinib in a Young Patient With ALK‐Positive NSCLC Harboring I1171N Mutation Post‐Alectinib Resistance
  Case Reports in Oncological Medicine 2026 DOI: 10.1155/crom/7372418
  +Save
• Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE Study)
  JCO Global Oncology 2025 DOI: 10.1200/GO-25-00032
  +Save
• Prevalence of multidrug resistant bloodstream infections in febrile neutropenic patients with hematolymphoid malignancies: A retrospective observational study from a newly established tertiary oncology center in India
  Cancer Research, Statistics, and Treatment 2023 DOI: 10.4103/crst.crst_266_22
  +Save
• Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective audit.
  Ecancermedicalscience 2022 DOI: 10.3332/ecancer.2022.1460
  +Save
• Optimizing the bed distribution system in resource-constrained settings
  Cancer Research, Statistics, and Treatment 2022 DOI: 10.4103/crst.crst_81_22
  +Save
• Romiplostim – A narrative drug review
  Cancer Research, Statistics, and Treatment 2022 DOI: 10.4103/crst.crst_17_22
  +Save